Jasnita Telekomindo Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Jasnita Telekomindo Tbk trades at Rp92 (market cap 101.76B, 13.41M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Jasnita Telekomindo Tbk and Organon Pharma Indonesia Tbk. are close in size by market cap. Which is the better fit depends on your goals.
| JAST | SCPI | |
|---|---|---|
Market Cap | 101.76B | 104.4B |
Volume | 13.41M | — |
Lot | 134.08K | — |
Turnover | 1.21B | — |
Average Price | 90.15 | — |
Value | 1.21B | — |
Indicative Equilibrium Price | 92 | — |
Indicative Equilibrium Volume | 2.94K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Jasnita Telekomindo Tbk ("Company") was established in January 25,1996 based on the Deed of Establishment No. 119 dated January 25, 1996 which made before Agus Madjid, S.H., Notary in Jakarta which was later amended by the Amendment Act Articles of Association No. 45 dated August 14, 1996 made before Susi Susilowaty Wisnu, S.H., Substitute Notary from Agus Madjid, S.H., Notary in Jakarta.
Read more on JAST →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →